BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY. Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017;15:1833-1843. [PMID: 28532700 DOI: 10.1016/j.cgh.2017.05.023] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 18.6] [Reference Citation Analysis]
Number Citing Articles
1 He L, Lei Y, Hou J, Wu J, Lv G. Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression. Onco Targets Ther 2020;13:5901-11. [PMID: 32606800 DOI: 10.2147/OTT.S257606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang J, Lv W, Lin Z, Wang X, Bu J, Su Y. Hsa_circ_0003159 inhibits gastric cancer progression by regulating miR-223-3p/NDRG1 axis. Cancer Cell Int 2020;20:57. [PMID: 32099530 DOI: 10.1186/s12935-020-1119-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
3 Nguyen TH, Tan MC, Liu Y, Rugge M, Thrift AP, El-Serag HB. Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population. Clin Gastroenterol Hepatol 2021;19:269-276.e3. [PMID: 32184184 DOI: 10.1016/j.cgh.2020.03.015] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Xie S, Chang Y, Jin H, Yang F, Xu Y, Yan X, Lin A, Shu Q, Zhou T. Non-coding RNAs in gastric cancer. Cancer Lett 2020;493:55-70. [PMID: 32712234 DOI: 10.1016/j.canlet.2020.06.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Tsering J, Hu X. Triphala Suppresses Growth and Migration of Human Gastric Carcinoma Cells In Vitro and in a Zebrafish Xenograft Model. Biomed Res Int 2018;2018:7046927. [PMID: 30643816 DOI: 10.1155/2018/7046927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Rugge M, Sacchi D, Genta RM, Zanco F, Guzzinati S, Pizzi M, Fassan M, Di Sabatino A, El-Serag H. Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency. Dig Liver Dis 2021;53:61-5. [PMID: 33004294 DOI: 10.1016/j.dld.2020.09.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA; WHO Classification of Tumours Editorial Board. Diagnosis of digestive system tumours. Int J Cancer 2021;148:1040-50. [PMID: 32674220 DOI: 10.1002/ijc.33210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Danilova N, Oleynikova N, Malkov P. 2019 WHO classification of gastric epithelial tumors, 5th edition. Arkh patol 2020;82:58. [DOI: 10.17116/patol20208204158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dávila-Collado R, Jarquín-Durán O, Dong LT, Espinoza JL. Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders. Pathogens 2020;9:E104. [PMID: 32041355 DOI: 10.3390/pathogens9020104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Rugge M, Sacchi D, Cesaro S, Sbaraglia M, Locatelli F. Ethics in clinical autopsy. J Clin Pathol 2020:jclinpath-2020-206793. [PMID: 33293353 DOI: 10.1136/jclinpath-2020-206793] [Reference Citation Analysis]
11 Khan AA, Nema V, Khan Z. Current status of probiotics for prevention and management of gastrointestinal cancers. Expert Opin Biol Ther 2021;21:413-22. [PMID: 33034210 DOI: 10.1080/14712598.2021.1828858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Basak D, Jamal Z, Ghosh A, Mondal PK, Dey Talukdar P, Ghosh S, Ghosh Roy B, Ghosh R, Halder A, Chowdhury A, Dhali GK, Chattopadhyay BK, Saha ML, Basu A, Roy S, Mukherjee C, Biswas NK, Chatterji U, Datta S. Reciprocal interplay between asporin and decorin: Implications in gastric cancer prognosis. PLoS One 2021;16:e0255915. [PMID: 34379688 DOI: 10.1371/journal.pone.0255915] [Reference Citation Analysis]
13 Deng X, Pi Y, Li Z, Xiong R, Liu J, Zhao J, Xie Z, Lei X, Tang G. FB-15 inhibits MGC-803 cells growth by regulating energy metabolism. Chem Biol Interact 2020;327:109186. [PMID: 32590071 DOI: 10.1016/j.cbi.2020.109186] [Reference Citation Analysis]
14 Ding SZ. Global whole family based-Helicobacter pylori eradication strategy to prevent its related diseases and gastric cancer. World J Gastroenterol 2020; 26(10): 995-1004 [PMID: 32205991 DOI: 10.3748/wjg.v26.i10.995] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
15 Selgrad M, Malfertheiner P. Management of Helicobacter pylori Infection: What Should the Surgeon Know? Visc Med 2017;33:216-9. [PMID: 28785571 DOI: 10.1159/000477977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Anderson WF, Rabkin CS, Turner N, Fraumeni JF Jr, Rosenberg PS, Camargo MC. The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites. J Natl Cancer Inst. 2018;110:608-615. [PMID: 29361173 DOI: 10.1093/jnci/djx262] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 24.3] [Reference Citation Analysis]
17 Liu D, Shi K, Fu M, Chen F. Placenta-specific protein 1 promotes cell proliferation via the AKT/GSK-3β/cyclin D1 signaling pathway in gastric cancer. IUBMB Life 2021;73:1131-41. [PMID: 34110086 DOI: 10.1002/iub.2514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yan TL, Gao JG, Wang JH, Chen D, Lu C, Xu CF. Current status of Helicobacter pylori eradication and risk factors for eradication failure. World J Gastroenterol 2020; 26(32): 4846-4856 [PMID: 32921961 DOI: 10.3748/wjg.v26.i32.4846] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Yang W, Wu B, Ma N, Wang Y, Guo J, Zhu J, Zhao S. BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling. In Vitro Cell Dev Biol -Animal 2019;55:445-52. [DOI: 10.1007/s11626-019-00360-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
21 Aumpan N, Vilaichone RK, Nunanan P, Chonprasertsuk S, Siramolpiwat S, Bhanthumkomol P, Pornthisarn B, Uchida T, Vilaichone V, Wongcha-Um A, Yamaoka Y, Mahachai V. Predictors for development of complete and incomplete intestinal metaplasia (IM) associated with H. pylori infection: A large-scale study from low prevalence area of gastric cancer (IM-HP trial). PLoS One 2020;15:e0239434. [PMID: 33002050 DOI: 10.1371/journal.pone.0239434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Businello G, Galuppini F, Fassan M. The impact of recent next generation sequencing and the need for a new classification in gastric cancer. Best Pract Res Clin Gastroenterol 2021;50-51:101730. [PMID: 33975684 DOI: 10.1016/j.bpg.2021.101730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Yu P, Wei K, Zhang T, Tan Z, Zhao H, Sun H. CircTMCO3 Promotes Gastric Cancer Progression by Regulating miR-577/RAB14 Axis. Cancer Manag Res 2021;13:6079-88. [PMID: 34377026 DOI: 10.2147/CMAR.S300559] [Reference Citation Analysis]
24 Yang Y, Zheng Y, Zhang H, Miao Y, Wu G, Zhou L, Wang H, Ji R, Guo Q, Chen Z, Wang J, Wang Y, Zhou Y. An Immune-Related Gene Panel for Preoperative Lymph Node Status Evaluation in Advanced Gastric Cancer. Biomed Res Int 2020;2020:8450656. [PMID: 33490257 DOI: 10.1155/2020/8450656] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Song R, Li Y, Hao W, Yang L, Chen B, Zhao Y, Sun B, Xu F. Circular RNA MTO1 inhibits gastric cancer progression by elevating PAWR via sponging miR-199a-3p. Cell Cycle 2020;19:3127-39. [PMID: 33089757 DOI: 10.1080/15384101.2020.1834301] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and Cancer: Friends or Faux? Int J Mol Sci 2020;21:E3115. [PMID: 32354115 DOI: 10.3390/ijms21093115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Miraglia C, Moccia F, Russo M, Scida S, Franceschi M, Crafa P, Franzoni L, Nouvenne A, Meschi T, Leandro G, De' Angelis GL, Di Mario F. Non-invasive method for the assessment of gastric acid secretion. Acta Biomed 2018;89:53-7. [PMID: 30561418 DOI: 10.23750/abm.v89i8-S.7986] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Zheng Y, Zhao Y, Di Y, Xiu C, He L, Liao S, Li D, Huang B. DNA aptamers from whole-serum SELEX as new diagnostic agents against gastric cancer. RSC Adv 2019;9:950-7. [DOI: 10.1039/c8ra08642g] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
29 Wang T, Ji R, Liu G, Ma B, Wang Z, Wang Q. Lactate induces aberration in the miR-30a-DBF4 axis to promote the development of gastric cancer and weakens the sensitivity to 5-Fu. Cancer Cell Int 2021;21:602. [PMID: 34758839 DOI: 10.1186/s12935-021-02291-2] [Reference Citation Analysis]
30 Di Mario F, Crafa P, Barchi A, Franzoni L, Franceschi M, Russo M, Bricca L, Brozzi L, Rodriguez Castro K, Rugge M. Pepsinogen II in gastritis and Helicobacter pylori infection. Helicobacter 2022;:e12872. [PMID: 34997989 DOI: 10.1111/hel.12872] [Reference Citation Analysis]
31 Pennelli G, Grillo F, Galuppini F, Ingravallo G, Pilozzi E, Rugge M, Fiocca R, Fassan M, Mastracci L. Gastritis: update on etiological features and histological practical approach. Pathologica 2020;112:153-65. [PMID: 33179619 DOI: 10.32074/1591-951X-163] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Wang Y, Shen L, Zhao G, Li B, Bu J, Zhu C, Jiang B, Wang S. Histomorphological Characteristics and Pathological Types of Hyperproliferation of Gastric Surface Epithelial Cells. Gastroenterol Res Pract 2021;2021:8828326. [PMID: 33777138 DOI: 10.1155/2021/8828326] [Reference Citation Analysis]
33 Do AD, Chang CC, Su CH, Hsu YM. Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions. Helicobacter 2021;26:e12806. [PMID: 33843101 DOI: 10.1111/hel.12806] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Wang D, Liu K, Chen E. LINC00511 promotes proliferation and invasion by sponging miR-515-5p in gastric cancer. Cell Mol Biol Lett 2020;25:4. [PMID: 32042282 DOI: 10.1186/s11658-020-0201-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
35 Shichijo S, Hirata Y. Characteristics and predictors of gastric cancer after Helicobacter pylori eradication. World J Gastroenterol 2018; 24(20): 2163-2172 [PMID: 29853734 DOI: 10.3748/wjg.v24.i20.2163] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
36 Cui Y, Zhou K, Strugatsky D, Wen Y, Sachs G, Zhou ZH, Munson K. pH-dependent gating mechanism of the Helicobacter pylori urea channel revealed by cryo-EM. Sci Adv 2019;5:eaav8423. [PMID: 30906870 DOI: 10.1126/sciadv.aav8423] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
37 Rugge M, Savarino E, Sbaraglia M, Bricca L, Malfartheiner P. Gastritis: The clinico-pathological spectrum. Dig Liver Dis 2021:S1590-8658(21)00100-6. [PMID: 33785282 DOI: 10.1016/j.dld.2021.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Xie SH, Chen H, Lagergren J. Causes of death in patients diagnosed with gastric adenocarcinoma in Sweden, 1970-2014: A population-based study. Cancer Sci 2020;111:2451-9. [PMID: 32359209 DOI: 10.1111/cas.14441] [Reference Citation Analysis]
39 Wang Z, Graham DY, Khan A, Balakrishnan M, Abrams HR, El-Serag HB, Thrift AP. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. Int J Epidemiol 2018;47:966-75. [PMID: 29672681 DOI: 10.1093/ije/dyy055] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
40 Shi Y, Qi L, Chen H, Zhang J, Guan Q, He J, Li M, Guo Z, Yan H, Li P. Identification of Genes Universally Differentially Expressed in Gastric Cancer. Biomed Res Int 2021;2021:7326853. [PMID: 33542925 DOI: 10.1155/2021/7326853] [Reference Citation Analysis]
41 Bornschein J, Rugge M. Bright future for endoscopy: the new frontier of gastric cancer secondary prevention. Gut 2020;69:1723-4. [PMID: 32532892 DOI: 10.1136/gutjnl-2020-321570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Wu JY, Lee YC, Graham DY. The eradication of Helicobacter pylori to prevent gastric cancer: A critical appraisal. Expert Rev Gastroenterol Hepatol. 2019;13:17-24. [PMID: 30791844 DOI: 10.1080/17474124.2019.1542299] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
43 Rugge M, Sacchi D, Graham DY, Genta RM. Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging. Gut 2020;69:1151-2. [PMID: 31186295 DOI: 10.1136/gutjnl-2019-319107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
44 Fassan M, Brignola S, Pennelli G, Alberti G, Angerilli V, Bressan A, Pellino A, Lanza C, Salmaso R, Lonardi S, Pucciarelli S, Spolverato G, Scarpa M, Realdon S, Farinati F, Luchini C, Rugge M, Loupakis F. PD-L1 expression in gastroesophageal dysplastic lesions. Virchows Arch 2020;477:151-6. [DOI: 10.1007/s00428-019-02693-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
45 Shen K, Yu W, Yu Y, Liu X, Cui X. Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer. Biomedicine & Pharmacotherapy 2018;104:576-81. [DOI: 10.1016/j.biopha.2018.05.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
46 Mahmoodi SA, Mirzaie K, Mahmoodi MS, Mahmoudi SM. A Medical Decision Support System to Assess Risk Factors for Gastric Cancer Based on Fuzzy Cognitive Map. Comput Math Methods Med 2020;2020:1016284. [PMID: 33082836 DOI: 10.1155/2020/1016284] [Reference Citation Analysis]
47 Costa L, Corre S, Michel V, Le Luel K, Fernandes J, Ziveri J, Jouvion G, Danckaert A, Mouchet N, Da Silva Barreira D, Torres J, Camorlinga M, D'Elios MM, Fiette L, De Reuse H, Galibert MD, Touati E. USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis. Gut 2020;69:1582-91. [PMID: 31822580 DOI: 10.1136/gutjnl-2019-318640] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
48 Rugge M, Genta RM, Fassan M, Valentini E, Coati I, Guzzinati S, Savarino E, Zorzi M, Farinati F, Malfertheiner P. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients. Am J Gastroenterol. 2018;113:1621-1628. [PMID: 30333540 DOI: 10.1038/s41395-018-0353-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
49 Delgado Guillena PG, Morales Alvarado VJ, Jimeno Ramiro M, Rigau Cañardo J, Ramírez Salazar C, García Rodríguez A, Córdova Guevara H, Fernández Esparrach G. Gastric cancer missed at esophagogastroduodenoscopy in a well-defined Spanish population. Digestive and Liver Disease 2019;51:1123-9. [DOI: 10.1016/j.dld.2019.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
50 Yao Q, Qi X, Xie SH. Sex difference in the incidence of cardia and non-cardia gastric cancer in the United States, 1992-2014. BMC Gastroenterol 2020;20:418. [PMID: 33308167 DOI: 10.1186/s12876-020-01551-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Chen Y, Liu B, Wei Y, Kuang DM. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy. Pharmacol Res 2021;174:105966. [PMID: 34728366 DOI: 10.1016/j.phrs.2021.105966] [Reference Citation Analysis]
52 Noto CN, DiPaolo RJ. More Testosterone, Less Aggression…At Least in the Stomach. Gastroenterology 2021;161:420-2. [PMID: 34048783 DOI: 10.1053/j.gastro.2021.05.046] [Reference Citation Analysis]
53 Chen DD, Cheng JT, Chandoo A, Sun XW, Zhang L, Lu MD, Sun WJ, Huang YP. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway. Am J Physiol Gastrointest Liver Physiol 2019;317:G147-60. [PMID: 30943047 DOI: 10.1152/ajpgi.00284.2018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
54 Kobayashi J, Kawakubo M, Fujii C, Arisaka N, Miyashita M, Sato Y, Komura H, Matoba H, Nakayama J. Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL. Proc Natl Acad Sci U S A 2021;118:e2016469118. [PMID: 33853940 DOI: 10.1073/pnas.2016469118] [Reference Citation Analysis]
55 Shan MJ, Meng LB, Guo P, Zhang YM, Kong D, Liu YB. Screening and Identification of Key Biomarkers of Gastric Cancer: Three Genes Jointly Predict Gastric Cancer. Front Oncol 2021;11:591893. [PMID: 34485109 DOI: 10.3389/fonc.2021.591893] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Sutradhar R, Asidianya N, Lee F, Coburn N, Rabeneck L, Paszat L. Higher risk of gastric cancer among immigrants to Ontario: a population-based matched cohort study with over 2 million individuals. Gastric Cancer 2018;21:588-97. [PMID: 29285629 DOI: 10.1007/s10120-017-0790-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Genta RM. Editorial: the post- Helicobacte r stomach-not the same for cohorts and individuals. Aliment Pharmacol Ther 2018;47:846-7. [DOI: 10.1111/apt.14491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Ansari S, Yamaoka Y. Current understanding and management of Helicobacter pylori infection: an updated appraisal. F1000Res. 2018;7. [PMID: 29946428 DOI: 10.12688/f1000research.14149.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
59 Rugge M, Dinis-ribeiro M. Letter: gastric atrophy assessment-merging serology, endoscopy and histology in clinical practice. Aliment Pharmacol Ther 2018;47:151-2. [DOI: 10.1111/apt.14383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
60 Alatan H, Chen Y, Zhou J, Wang L. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis. Genes (Basel) 2021;12:1104. [PMID: 34356118 DOI: 10.3390/genes12071104] [Reference Citation Analysis]
61 Xu Y, Feng S, Niu B. Silencing Stat3 inhibits viability and induces apoptosis in BGC-823 human gastric cancer cell line. Biotech Histochem 2021;96:76-81. [PMID: 32619110 DOI: 10.1080/10520295.2020.1770332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
62 Coelho LGV, Marinho JR, Genta R, Ribeiro LT, Passos MDCF, Zaterka S, Assumpção PP, Barbosa AJA, Barbuti R, Braga LL, Breyer H, Carvalhaes A, Chinzon D, Cury M, Domingues G, Jorge JL, Maguilnik I, Marinho FP, Moraes-filho JPD, Parente JML, Paula-e-silva CMD, Pedrazzoli-júnior J, Ramos AFP, Seidler H, Spinelli JN, Zir JV. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. Arq Gastroenterol 2018;55:97-121. [DOI: 10.1590/s0004-2803.201800000-20] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
63 Lin Y, Zheng Y, Wang HL, Wu J. Global Patterns and Trends in Gastric Cancer Incidence Rates (1988-2012) and Predictions to 2030. Gastroenterology 2021;161:116-127.e8. [PMID: 33744306 DOI: 10.1053/j.gastro.2021.03.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Cammarota G, Ianiro G, Ahern A, Carbone C, Temko A, Claesson MJ, Gasbarrini A, Tortora G. Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nat Rev Gastroenterol Hepatol 2020;17:635-48. [DOI: 10.1038/s41575-020-0327-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 15.5] [Reference Citation Analysis]
65 Ness-Jensen E, Bringeland EA, Mattsson F, Mjønes P, Lagergren J, Grønbech JE, Waldum HL, Fossmark R. Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population-based nested case-control study. Int J Cancer 2021;148:1879-86. [PMID: 33091962 DOI: 10.1002/ijc.33354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Fan WD, Chen T, Liu PJ. NIMA related kinase 2 promotes gastric cancer cell proliferation via ERK/MAPK signaling. World J Gastroenterol 2019; 25(23): 2898-2910 [PMID: 31249448 DOI: 10.3748/wjg.v25.i23.2898] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
67 Shao S, Li S, Liu C, Zhang W, Zhang Z, Zhu S, Feng Y, Pan Y. Toosendanin induces apoptosis of MKN‑45 human gastric cancer cells partly through miR‑23a‑3p‑mediated downregulation of BCL2. Mol Med Rep 2020;22:1793-802. [PMID: 32582989 DOI: 10.3892/mmr.2020.11263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Cai WY, Lin LY, Wang L, Yang L, Ye GD, Zeng Q, Cheng J, Xie YY, Chen ML, Luo QC. Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice. Cell Commun Signal 2019;17:72. [PMID: 31288844 DOI: 10.1186/s12964-019-0387-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
69 Chen D, Xiong L, Zhang L, Yu H, Xu Y, Wang M, Jiang X, Xiong Z. CSF1R is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in the Gastric Cancer Microenvironment. Pharmgenomics Pers Med 2021;14:445-57. [PMID: 33880056 DOI: 10.2147/PGPM.S301303] [Reference Citation Analysis]
70 Akbari M, Tabrizi R, Kardeh S, Lankarani KB. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. PLoS One 2019;14:e0219865. [PMID: 31348819 DOI: 10.1371/journal.pone.0219865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
71 Watari J, Tomita T, Tozawa K, Oshima T, Fukui H, Miwa H. Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin. Gut Liver 2020;14:281-90. [PMID: 31547640 DOI: 10.5009/gnl19079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, Pennelli G, Mastracci L, Saragoni L, Fassan M. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions. Int J Mol Sci 2021;22:9950. [PMID: 34576114 DOI: 10.3390/ijms22189950] [Reference Citation Analysis]
73 Yao CC, Kuo CM, Hsu CN, Yang SC, Wu CK, Tai WC, Liang CM, Wu KL, Huang CF, Bi KW, Lee CH, Chuah SK. First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus. Infect Drug Resist 2019;12:1425-31. [PMID: 31239721 DOI: 10.2147/IDR.S194584] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
74 Yao Q, Qi X, Cheng W, Xie SH. A Comprehensive Assessment of the Racial and Ethnic Disparities in the Incidence of Gastric Cancer in the United States, 1992-2014. Cancer Res Treat 2019;51:519-29. [PMID: 29921118 DOI: 10.4143/crt.2018.146] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
75 Park JM, Han YM, Hwang SJ, Kim SJ, Hahm KB. Therapeutic effects of placenta derived-, umbilical cord derived-, and adipose tissue derived-mesenchymal stem cells in chronic Helicobacter pylori infection: comparison and novel mechanisms. J Clin Biochem Nutr 2021;69:188-202. [PMID: 34616110 DOI: 10.3164/jcbn.20-151] [Reference Citation Analysis]
76 Wang S, Cheng Y, Yang P, Qin G. Silencing of Long Noncoding RNA LINC00324 Interacts with MicroRNA-3200-5p to Attenuate the Tumorigenesis of Gastric Cancer via Regulating BCAT1. Gastroenterol Res Pract 2020;2020:4159298. [PMID: 32855634 DOI: 10.1155/2020/4159298] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
77 El-Serag HB, Kao JY, Kanwal F, Gilger M, LoVecchio F, Moss SF, Crowe SE, Elfant A, Haas T, Hapke RJ, Graham DY. Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol 2018;16:992-1002.e6. [PMID: 29559361 DOI: 10.1016/j.cgh.2018.03.013] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 17.8] [Reference Citation Analysis]
78 Bravo LE, García LS, Collazos P, Carrascal E, Ramírez O, Collazos T, Cortés A, Nuñez M, Millan E. Reliable information for cancer control in Cali, Colombia. Colomb Med (Cali) 2018;49:23-34. [PMID: 29983461 DOI: 10.25100/cm.v49i1.3689] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
79 Wu R, Yang C, Ji L, Fan ZN, Tao YW, Zhan Q. Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric. BMC Cancer 2020;20:1110. [PMID: 33198658 DOI: 10.1186/s12885-020-07612-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Rugge M. Gastric cancer risk: between genetics and lifestyle. Lancet Oncol 2020;21:1258-60. [PMID: 33002433 DOI: 10.1016/S1470-2045(20)30432-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
81 Du Y, Zhu H, Liu J, Li J, Chang X, Zhou L, Chen M, Lu N, Li Z. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai). J Gastroenterol Hepatol. 2020;35:624-629. [PMID: 31788864 DOI: 10.1111/jgh.14947] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
82 Jaka H, Rüttgerodt N, Bohne W, Mueller A, Gross U, Kasang C, Mshana SE. Helicobacter pylori Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania. Can J Gastroenterol Hepatol 2019;2019:8481375. [PMID: 31355162 DOI: 10.1155/2019/8481375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
83 Li X, Chen S, Zhu Y, Fei J, Song L, Sun G, Niu W, Guo L, Wang J. Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer. J Gastrointest Oncol 2021;12:2132-49. [PMID: 34790380 DOI: 10.21037/jgo-21-598] [Reference Citation Analysis]
84 Tan B, Li Y, Zhao Q, Fan L, Wang D. ZNF139 increases multidrug resistance in gastric cancer cells by inhibiting miR-185. Biosci Rep 2018;38:BSR20181023. [PMID: 30126848 DOI: 10.1042/BSR20181023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
85 Shen B, Qian A, Lao W, Li W, Chen X, Zhang B, Wang H, Yuan F, Sun Y. Relationship between Helicobacter pylori and expression of programmed death-1 and its ligand in gastric intraepithelial neoplasia and early-stage gastric cancer. Cancer Manag Res 2019;11:3909-19. [PMID: 31190978 DOI: 10.2147/CMAR.S203035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
86 Planade O, Dessomme B, Chapelle N, Verdier M, Duchalais E, Queneherve L, Le Rhun M, Coron E, Mosnier JF, Matysiak-Budnik T, Touchefeu Y. Systematic upper endoscopy concomitant with colonoscopy performed within the colorectal cancer screening program: Impact on the patients' management. Clin Res Hepatol Gastroenterol 2021;45:101501. [PMID: 33714864 DOI: 10.1016/j.clinre.2020.07.006] [Reference Citation Analysis]
87 Alexander KL, Serrano CA, Chakraborty A, Nearing M, Council LN, Riquelme A, Garrido M, Bellis SL, Smythies LE, Smith PD. Modulation of glycosyltransferase ST6Gal-I in gastric cancer-derived organoids disrupts homeostatic epithelial cell turnover. J Biol Chem 2020;295:14153-63. [PMID: 32763973 DOI: 10.1074/jbc.RA120.014887] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
88 Dang SC, Fan YY, Cui L, Chen JX, Qu JG, Gu M. PLK1 as a potential prognostic marker of gastric cancer through MEK-ERK pathway on PDTX models. Onco Targets Ther 2018;11:6239-47. [PMID: 30288059 DOI: 10.2147/OTT.S169880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
89 Deng X, Li Z, Xiong R, Liu J, Liu R, Peng J, Chen Y, Lei X, Cao X, Zheng X, Xie Z, Tang G. FS-7 inhibits MGC-803 cells growth in vitro and in vivo via down-regulating glycolysis. Biomedicine & Pharmacotherapy 2019;109:1659-69. [DOI: 10.1016/j.biopha.2018.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
90 Pellino A, Riello E, Nappo F, Brignola S, Murgioni S, Djaballah SA, Lonardi S, Zagonel V, Rugge M, Loupakis F, Fassan M. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives. World J Gastroenterol 2019; 25(38): 5773-5788 [PMID: 31636471 DOI: 10.3748/wjg.v25.i38.5773] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
91 Zhang Y, Feng XY, Li GQ, Xu F, Liu F, Li YY, Deng B. Epidemiological study of Helicobacter pylori infection and its relationship with pathologic changes of the antral mucosa in rural areas of Yangzhou. Shijie Huaren Xiaohua Zazhi 2021; 29(10): 550-556 [DOI: 10.11569/wcjd.v29.i10.550] [Reference Citation Analysis]
92 Yılmaz N, Koruk Özer M. The Prevalence of Helicobacter Pylori babA, homB, aspA, and sabA Genes and Its Relationship with Clinical Outcomes in Turkey. Can J Gastroenterol Hepatol 2019;2019:1271872. [PMID: 31312620 DOI: 10.1155/2019/1271872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Aumpan N, Vilaichone RK, Gamnarai P, Sanglutong L, Ratanachu-Ek T, Mahachai V, Yamaoka Y. Prevalence and Antibiotic Resistance Patterns of Helicobacter pylori Infection in Koh Kong, Cambodia. Asian Pac J Cancer Prev 2020;21:1409-13. [PMID: 32458649 DOI: 10.31557/APJCP.2020.21.5.1409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Rugge M, Sugano K, Scarpignato C, Sacchi D, Oblitas WJ, Naccarato AG. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging. Helicobacter. 2019;24:e12571. [PMID: 30773732 DOI: 10.1111/hel.12571] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
95 Ye DM, Xu G, Ma W, Li Y, Luo W, Xiao Y, Liu Y, Zhang Z. Significant function and research progress of biomarkers in gastric cancer. Oncol Lett 2020;19:17-29. [PMID: 31897111 DOI: 10.3892/ol.2019.11078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
96 Han XL, Yi CL, Ma JD, He Y, Wu LM, Wang YF, Yang HJ, Liang DY, Shi JF. Clinical Value of Pepsinogen in the Screening, Prevention, and Diagnosis of Gastric Cancer. Lab Med 2021:lmab035. [PMID: 34508270 DOI: 10.1093/labmed/lmab035] [Reference Citation Analysis]
97 Buzás GM. Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018. Minerva Gastroenterol Dietol 2018;64:280-96. [PMID: 29458240 DOI: 10.23736/S1121-421X.18.02481-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]